UPON

Zuma Capital Management Nominates Five Highly Qualified, Independent Director Candidates at Presidio Property Trust

Retrieved on: 
水曜日, 3月 13, 2024
Centurion, Resort, Letter, Spinal muscular atrophies, Exercise, Warrant, Trust, Telecommunications, Private law, Employment, TSR, WHEN, International, Compensated emancipation, Common stock, Research, Senior counsel, Security (finance), Retirement, UPON, Fear, Principal, PC, Assistant, Shareholder, Total shareholder return, Common, Capital, Highfields Capital Management, Axos Bank, Partner, WEB

ATLANTA, March 13, 2024 (GLOBE NEWSWIRE) -- Zuma Capital Management, LLC, which owns approximately 7.7% of the outstanding shares of the Series A Common Stock of Presidio Property Trust, Inc. (NASDAQ: SQFT) (“Presidio” or the “Company”), today issued a public letter to the Company’s stockholders announcing its nomination of five highly qualified, independent candidates; Reuben Berman, Stefani Carter, Vito Garfi, Brent Morrison and Elena Piliptchak, for election to the Company’s Board of Directors at the Company’s 2024 Annual Meeting of Stockholders.

Key Points: 
  • Learn more about Zuma Capital Management, LLC’s director candidates by visiting www.SavePresidio.com, where stockholders can download a copy of our letter and sign up for future updates on Zuma Capital Management’s campaign for boardroom change.
  • We have nominated five highly qualified, independent candidates for election to the Board, who have strong experience in commercial real estate, corporate governance and capital allocation.
  • 2 Source: Morningstar (as of March 12, 2024) and Zuma Capital Management Internal Estimates.
  • 3 Source: Morningstar (as of March 12, 2024) and Zuma Capital Management Internal Estimates.

Rubric Capital Management Nominates Two Highly Qualified, Independent Directors to Xperi Inc. Board of Directors

Retrieved on: 
月曜日, 3月 11, 2024
Asset Management, Professional Services, Finance, Failure, Health, History, Sale, Marketing, Corporation, TSRA, Immersion, INTC, WHEN, Phoenix Technologies, Interim, DSP Group, Common stock, Knowledge, AI, Security (finance), Senior, UPON, Intel, Immersion Corporation, Growth, International Rectifier, Common, Capital, Management

David Rosen, Managing Partner of Rubric, said, “Xperi has built an attractive portfolio of innovative enablement technologies with significant monetization potential.

Key Points: 
  • David Rosen, Managing Partner of Rubric, said, “Xperi has built an attractive portfolio of innovative enablement technologies with significant monetization potential.
  • The participants in the proxy solicitation are anticipated to be Rubric Master, Rubric Capital GP LLC (“Rubric Master GP”), Rubric Capital Management LP (“Rubric Capital”), Rubric Capital Management GP LLC (“Rubric Capital GP”), David Rosen, Deborah S. Conrad and Thomas A. Lacey.
  • As of the date hereof, 625,756 shares of Common Stock are held in certain accounts managed by Rubric Capital (the “Rubric Accounts”).
  • Rubric Capital GP, as the general partner of Rubric Capital, may be deemed the beneficial owner of the 4,043,744 shares of Common Stock owned in the aggregate by Rubric Master and held in the Rubric Accounts.

Concerned Stockholders of Nikola Corp. Introduce Slate of Independent Director Candidates for Election to the Company’s Board at the 2024 Annual Meeting

Retrieved on: 
火曜日, 2月 20, 2024
Professional Services, Automotive, Automotive Manufacturing, EV, Electric Vehicles, Manufacturing, Finance, Engineering, Iveco, Certificate, Sale, University, PLLC, M&M, Supply chain management, Concerned, Social media, Transport, Business administration, Security (finance), Brigham Young University, Partnership, Common stock, WHEN, Shop, Safety, Authorization, Business, Chair, Marriott School, Marketing, TSR, Entrepreneurship, Risk, WAV, Nikola Corporation, UPON, Management

Today, the Concerned Stockholder Group issued the below statement regarding its nomination of five highly qualified and independent director candidates for election to the Company’s nine-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).

Key Points: 
  • Today, the Concerned Stockholder Group issued the below statement regarding its nomination of five highly qualified and independent director candidates for election to the Company’s nine-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).
  • Our slate of director candidates is highly qualified, wholly independent and focused on one goal: implementing a lasting turnaround that unlocks the significant potential of Nikola.
  • In fact, our Group has been approached by numerous stockholders who want to see CEO Steve Girsky and his Board replaced with high-integrity individuals.
  • TSR includes dividends reinvested using a closing price of February 8, 2024, the day before Nikola made the Group’s nomination public.

Crown Castle Co-Founder Ted B. Miller Issues Statement on Crown Castle's Rewrite of Cooperation Agreement with Elliott

Retrieved on: 
月曜日, 3月 4, 2024
Boot, Participation, Crown Castle, ANY, Common stock, WHEN, Common, Tenant, Annual general meeting, GOLD, Security (finance), WRCB, UPON, Corporation, AS, Investment

HOUSTON, March 4, 2024 /PRNewswire/ -- Ted B. Miller, co-founder of Crown Castle Inc. (NYSE: CCI) ("Crown Castle" or the "Company") and his investment vehicle Boots Capital Management, LLC ("Boots Capital") today issued the following statement:

Key Points: 
  • Similarly, statements that describe the Participants' (as defined below) objectives, plans or goals are forward-looking.
  • There can be no assurance that any idea or assumption herein is, or will be proven, correct.
  • BOOTS CAPITAL STRONGLY ADVISES ALL SHAREHOLDERS OF CROWN CASTLE TO READ THE PRELIMINARY PROXY STATEMENT, ANY AMENDMENTS OR SUPPLEMENTS TO SUCH PROXY STATEMENT, THE DEFINITIVE PROXY STATEMENT, AS WELL AS PROXY MATERIALS FILED BY CROWN CASTLE AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.

Crown Castle Co-Founder Ted B. Miller Files Lawsuit to Invalidate Crown Castle's Unlawful Cooperation Agreement with Elliott

Retrieved on: 
水曜日, 2月 28, 2024
Boot, Participation, Crown Castle, ANY, Common stock, WHEN, Cardinal Health, Common, Tenant, Annual general meeting, GOLD, Security (finance), WRCB, UPON, Corporation, AS, Investment

HOUSTON, Feb. 28, 2024 /PRNewswire/ -- Ted B. Miller, co-founder of Crown Castle Inc. (NYSE: CCI) ("Crown Castle" or the "Company") and his investment vehicle Boots Capital Management, LLC ("Boots Capital") today filed a complaint in the Court of Chancery of the State of Delaware (the "Court") seeking to invalidate the cooperation agreement between Crown Castle's Board of Directors (the "Board") and Elliott Investment Management, L.P. (together with its affiliates, "Elliott") announced on December 20, 2023. Under the terms of the cooperation agreement, Elliott and the Company appointed two new directors, Jason Genrich, Partner at Elliott, and Sunit Patel, Chief Financial Officer of Ibotta Inc. (collectively, the "Elliott Directors"), to the Board. Elliott received substantial governance rights without the customary provision that it be required to maintain an equity ownership position in the Company.1

Key Points: 
  • Similarly, statements that describe the Participants' (as defined below) objectives, plans or goals are forward-looking.
  • There can be no assurance that any idea or assumption herein is, or will be proven, correct.
  • IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.
  • 1 For example, Pinterest, Inc. entered into a cooperation agreement with Elliott on December 6, 2022, and Cardinal Health, Inc. entered into a cooperation agreement with Elliott on September 5, 2022, which each required that Elliott maintain an equity ownership threshold of 4.3% and 2.25%, respectively.

Jonathan Milner Issues Statement Responding to the Glass Lewis Report

Retrieved on: 
月曜日, 10月 23, 2023
ACT, MAKE, ITS, TAX, FOR, PAST, FAIR, DATE, AS, UPDATE, SET, ANY, NO, AMERICA, FCA, EUROPEAN UNION, BY, FUTURE, FINANCIAL, III, TIME, UPON, NOT, EACH, AND, ALL, PER, THIS, OF, EXPRESS, AWARE, IS, NORTH, USE, IT, Glass fiber, Medical device, Audit, EU

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner Issues Statement Responding to ISS Report

Retrieved on: 
月曜日, 10月 16, 2023
MAKE, ACT, III, AWARE, NO, AMERICA, NOT, PAST, TIME, DATE, THIS, AS, NORTH, USE, ANY, OF, IT, FOR, UPON, FINANCIAL, FCA, ITS, SET, IS, TAX, EXPRESS, EUROPEAN UNION, ALL, FAIR, UPDATE, BY, FUTURE, EACH, AND, Glass fiber, Medical device, Audit, EU

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company

Retrieved on: 
月曜日, 10月 16, 2023
ACT, MAKE, III, AWARE, NO, AMERICA, NOT, PAST, TIME, DATE, THIS, AS, NORTH, USE, ANY, OF, IT, FOR, UPON, PER, FINANCIAL, FCA, ITS, SET, IS, TAX, EXPRESS, EUROPEAN UNION, ALL, FAIR, UPDATE, BY, FUTURE, EACH, AND, Glass fiber, Medical device, Audit, EU

DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.

Key Points: 
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER IS NOT RESPONSIBLE TO ANY PERSON FOR PROVIDING ADVICE IN RELATION TO THE SUBJECT MATTER OF THIS DOCUMENT.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Retrieved on: 
火曜日, 10月 10, 2023
MAKE, ACT, III, AWARE, NO, AMERICA, NOT, PAST, TIME, DATE, THIS, AS, NORTH, USE, ANY, OF, IT, FOR, UPON, FINANCIAL, FCA, ITS, SET, IS, TAX, EXPRESS, EUROPEAN UNION, ALL, FAIR, UPDATE, BY, FUTURE, EACH, AND, Glass fiber, Medical device, Audit, EU

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board

Retrieved on: 
木曜日, 9月 14, 2023
MAKE, ACT, AS, UPON, FOR, TAX, OF, NO, PAST, ITS, TIME, EACH, DATE, FINANCIAL, FUTURE, AND, IT, III, NORTH, BY, NOT, UPDATE, ALL, THIS, AMERICA, SET, USE, FCA, EUROPEAN UNION, AWARE, EXPRESS, IS, ANY, FAIR, Medical device, Audit, EU

T: +44 (0)20 3709 5700 / E: [email protected]

Key Points: 
  • T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER IS NOT RESPONSIBLE TO ANY PERSON FOR PROVIDING ADVICE IN RELATION TO THE SUBJECT MATTER OF THIS DOCUMENT.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.